SWARTZ ROBIN (Chief Operating Officer) sold 6.4% of their position (6.95K shares) of VOYAGER THERAPEUTICS, INC. on the open market
Open‑market sale worth $30.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/12/2025ACC: 0001104659-25-012198
Officer· Chief Operating Officer
Since Feb 2022
-6.95K
Net shares
Net seller
$30.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
6.95K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−6.95K
Price / share
$4.45
Trade value
$30.93K
% of position
6.4%
2/11/2025
109.24K→102.29K
Total
Net shares
−6.95K
Net value
-$30.93K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/11/2025 | S · Sale | −6.95K | $4.45 | $30.93K | 6.4% | 109.24K | 102.29K |
| Total | −6.95K | -$30.93K | ||||||
Derivative Transactions0
No derivative transactions reported